Avalo Therapeutics
AVTX
AVTX
7 hedge funds and large institutions have $3.35M invested in Avalo Therapeutics in 2015 Q4 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
7
Holders Change
+7
Holders Change %
–
% of All Funds
0.18%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
7
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
MAM
1
MPM Asset Management
Boston,
Massachusetts
| $2M | 595,436 | +595,436 | New |
|
|
NMC
2
NEA Management Company
Timonium,
Maryland
| $1.2M | 595,435 | +595,435 | New |
|
|
BCCM
3
Blue Clay Capital Management
Minneapolis,
Minnesota
| $140K | 41,802 | +41,802 | New |
|
4
Citadel Advisors
Miami,
Florida
| $19K | 5,624 | +5,624 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $3K | 900 | +900 | New |
|
6
UBS Group
Zurich,
Switzerland
| $1K | 153 | +153 | New |
|
7
Morgan Stanley
New York
| $0 | 15 | +15 | New |
|